Sanber K, Ye K, Tsai HL, Newman M, et al. Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease. Leuk Lymphoma 2023 Feb 6:1-10. doi: 10.1080/10428194.2023.2173523.
PMID: 36744656